Liberty Shoes Ltd. (NSE:LIBERTSHOE)

G1 Therapeutics Revenue

Liberty Shoes had revenue of 1.73B INR in the quarter ending June 30, 2025, with 10.81% growth. This brings the company's revenue in the last twelve months to 6.92B, up 6.61% year-over-year. In the fiscal year ending March 31, 2025, Liberty Shoes had annual revenue of 6.75B with 6.06% growth.

• Revenue (ttm): 6.92B
• Revenue Growth: +6.61%
• P/S Ratio: 0.76
• Revenue / Employee: 3.38M
• Employees: 2,047
• Market Cap: 5.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	6.75B	386.21M	6.06%
Mar 31, 2024	6.37B	-174.68M	-2.67%
Mar 31, 2023	6.54B	1.67B	34.13%
Mar 31, 2022	4.88B	318.49M	6.98%
Mar 31, 2021	4.56B	-1.94B	-29.80%